Review of some pharmacokinetic and pharmacodynamic properties of anti‐infective medicines administered to the koala (Phascolarctos cinereus)
Author:
- 13 July 2017
- journal article
- review article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 41 (1) , 1-10
Abstract
Although koalas are iconic Australian animals, no pharmacokinetic studies of any first‐line medicines used to treat diseased or injured koalas had been published prior to 2010. Traditionally, medicine dosages suggested for this species underwent linear extrapolation from those recommended for domesticated species. The koala, a specialist folivore whose natural diet consists of almost exclusivelyEucalyptusspp. foliage has anatomical and physiological adaptations for detoxifying their diet which also affect medicine pharmacokinetic profiles. This review addresses aspects of medicine absorption, clearance, and other indices (such as medicine binding to plasma proteins) of enrofloxacin/marbofloxacin and chloramphenicol used for the systemic treatment of chlamydiosis, and fluconazole ± amphotericin, and posaconazole for the treatment of cryptococcosis. Based on observations from published studies, this review includes suggestions to improve therapeutic outcomes when administering medicines to diseased koalas.Keywords
This publication has 76 references indexed in Scilit:
- Koala retroviruses: characterization and impact on the life of koalasRetrovirology, 2013
- Pharmacokinetics of meloxicam in koalas (Phascolarctos cinereus) after intravenous, subcutaneous and oral administrationJournal of Veterinary Pharmacology and Therapeutics, 2013
- Pharmacokinetics of chloramphenicol following administration of intravenous and subcutaneous chloramphenicol sodium succinate, and subcutaneous chloramphenicol, to koalas (Phascolarctos cinereus)Journal of Veterinary Pharmacology and Therapeutics, 2012
- Disseminated Coccidoidomycosis in a Koala (Phascolarctos cinereus)Journal of Zoo and Wildlife Medicine, 2012
- Plasma concentrations of chloramphenicol after subcutaneous administration to koalas (Phascolarctos cinereus) with chlamydiosisJournal of Veterinary Pharmacology and Therapeutics, 2011
- Heteroresistance of Cryptococcus gattii to FluconazoleAntimicrobial Agents and Chemotherapy, 2010
- Identification and characterization of two chloramphenicol glucuronides from thein vitroglucuronidation of chloramphenicol in human liver microsomesXenobiotica, 2007
- Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and inductionExpert Opinion on Drug Metabolism & Toxicology, 2006
- CYP3A in horse intestinesToxicology and Applied Pharmacology, 2004
- Pharmacokinetics of fluconazole in cats after intravenous and oral administrationResearch in Veterinary Science, 1994